Are Medical Stocks Lagging Atossa Genetics (ATOS) This Year?
Werte in diesem Artikel
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Atossa Genetics Inc. (ATOS) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Atossa Genetics Inc. is a member of the Medical sector. This group includes 1023 individual stocks and currently holds a Zacks Sector Rank of #3. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Atossa Genetics Inc. is currently sporting a Zacks Rank of #2 (Buy).Over the past three months, the Zacks Consensus Estimate for ATOS' full-year earnings has moved 7.1% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.According to our latest data, ATOS has moved about 61.4% on a year-to-date basis. In comparison, Medical companies have returned an average of 5.1%. As we can see, Atossa Genetics Inc. is performing better than its sector in the calendar year.Another stock in the Medical sector, Cardinal Health (CAH), has outperformed the sector so far this year. The stock's year-to-date return is 10%.The consensus estimate for Cardinal Health's current year EPS has increased 0.9% over the past three months. The stock currently has a Zacks Rank #2 (Buy).To break things down more, Atossa Genetics Inc. belongs to the Medical - Instruments industry, a group that includes 86 individual companies and currently sits at #53 in the Zacks Industry Rank. This group has gained an average of 5.1% so far this year, so ATOS is performing better in this area.In contrast, Cardinal Health falls under the Medical - Dental Supplies industry. Currently, this industry has 17 stocks and is ranked #100. Since the beginning of the year, the industry has moved -0.4%.Atossa Genetics Inc. and Cardinal Health could continue their solid performance, so investors interested in Medical stocks should continue to pay close attention to these stocks.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 228 positions with double- and triple-digit gains in 2023 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Atossa Genetics Inc. (ATOS): Free Stock Analysis Report Cardinal Health, Inc. (CAH): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Atossa Genetics
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Atossa Genetics
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Atossa Genetics Inc Registered Shs
Analysen zu Atossa Genetics Inc Registered Shs
Datum | Rating | Analyst | |
---|---|---|---|
26.01.2018 | Atossa Genetics Buy | Maxim Group |
Datum | Rating | Analyst | |
---|---|---|---|
26.01.2018 | Atossa Genetics Buy | Maxim Group |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Atossa Genetics Inc Registered Shs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen